Healthy Living After Knee Replacement

NCT ID: NCT05190666

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

181 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-04

Study Completion Date

2027-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine if a weight loss program designed for adults after knee replacement improves weight loss, physical activity, pain, and function, as well as if the program is cost effective, as compared to a chronic disease self-management program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be randomized to either a weight loss program or chronic disease self-management program. Both programs will be phone-based and include phone calls with a health coach weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12. Monthly calls with occur between months 13-18. Assessments examining outcomes will be completed at baseline, 6, 12, and 18 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PACE Weight Loss Program

Participants randomized to this arm will receive personalized diet, activity, and weight loss goals as well as tools to self-monitor behaviors and weight. To facilitate changes, participants will receive coaching calls weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12.

Group Type EXPERIMENTAL

PACE Weight Loss program

Intervention Type BEHAVIORAL

12 month phone-based behavioral weight loss program

Chronic Disease Self-Management Program

Participants randomized to this arm will receive a chronic disease self-management program including a self-management book. Participants will receive regular calls weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12.

Group Type SHAM_COMPARATOR

Chronic Disease Self-Management

Intervention Type BEHAVIORAL

12 month phone-based chronic disease self-management program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PACE Weight Loss program

12 month phone-based behavioral weight loss program

Intervention Type BEHAVIORAL

Chronic Disease Self-Management

12 month phone-based chronic disease self-management program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants must:

* have a body mass index between 25-45 kg/m2
* have had a knee replacement (including primary, staged or independent bilateral, or revision) \<6 months prior to baseline assessment
* have a computer, tablet, or smartphone with active internet access to self-monitor online and/or have a device or computer compatible with Fitbit
* completion of baseline assessment measures (height, weight, function tests, surveys, ≥4 days valid of activity monitoring, and 1 day of dietary recall)
* be English-speaking and able to read consent and study materials written in English
* be willing to attend 4 in-person assessments.

Exclusion Criteria

* have any contraindications to diet or weight loss
* undergo simultaneous bilateral knee replacement or have a scheduled or anticipated knee replacement for the contralateral knee within the next 18 months
* have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinal stenosis, fibromyalgia, peripheral vascular disease, stroke)
* are taking anti-obesity medications
* are enrolled in a formal weight loss program
* had or are planning to have bariatric/gastric/lap band surgery
* are planning to relocate out of the Columbia or Greenville, SC areas in the next 18 months.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christine A Pellegrini, PhD

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christine Pellegrini, PhD

Role: PRINCIPAL_INVESTIGATOR

University of South Carolina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Carolina

Columbia, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AG070004

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00109459

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Weight Gain Prevention
NCT00606840 COMPLETED NA